A bill promoting the use of ivermectin, hydroxychloroquine, and other widely censored COVID-19 treatments was introduced in the Ohio House.
House Bill 631, introduced by Rep. Kris Jordan (R-Ostrander) late Thursday, protects and encourages the use of ivermectin, hydroxychloroquine, and other drugs bashed by the FDA to treat COVID-19.
Several Ohio House Republicans have revived efforts to expand COVID-19 patients’ access to ivermectin, hydroxychloroquine, and other drugs that have been shown to be ineffective in treating the disease https://t.co/62ZkqbNqde #10TV
— 10TV (@10TV) April 22, 2022
So long as a patient or a patient’s representative consents to the treatment – and a health care provider deems its use appropriate – Ohioans diagnosed with COVID-19 are eligible to receive drugs like ivermectin or other “alternative treatments,” Jordan’s bill reads.
Dr. Iahn Gonsenhauser, the chief quality and patient safety officer at Ohio State’s Wexner Medical Center, said the bill’s promotion of unauthorized drugs “absolutely” poses a threat to the health of Ohioans.
As some state lawmakers resisted the deployment of the COVID-19 vaccine citing unclear effects – despite widespread authorization from health agencies – Gonsenhauser said the supporters of HB 631 are hypocritical for backing a bill steeped in fruitless claims.
“Those same individuals are now introducing a bill that supports the use of therapies that are not intended to treat COVID, have been proven – really beyond a shadow of a doubt – to be unsuccessful in the treatment of COVID, and have actually been shown to have significant safety consequences,” Gonsenhauser said.
WeLoveTrump has reported the inconvenient truth about ivermectin and hydroxychloroquine the mainstream media and Big Pharma wants censored from the web.
From Ohio House Bill 631:
Subject to divisions (B)(2) and (3) of this section, a patient who has been diagnosed with SARS-CoV-2, including its variants, or COVID-19 may use any of the following drugs or therapies, either alone or in combination with other available drugs and therapies:
(e) Any other drug or therapy that may be proven effective or deemed beneficial by the patient’s treating health care professional in consultation with the patient or patient’s legally authorized representative.